|
|
|
|
| LEADER |
00000cam a22000003i 4500 |
| 001 |
EBOOKCENTRAL_ocn902942425 |
| 003 |
OCoLC |
| 005 |
20240329122006.0 |
| 006 |
m o d |
| 007 |
cr ||||||||||| |
| 008 |
141220s2012 dcu o 000 0 eng d |
| 040 |
|
|
|a YDXCP
|b eng
|e pn
|c YDXCP
|d OCLCQ
|d EBLCP
|d OCLCQ
|d ZCU
|d MERUC
|d ICG
|d OCLCF
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCQ
|d DKC
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCL
|
| 019 |
|
|
|a 923289264
|
| 020 |
|
|
|a 0309253160
|q (electronic bk.)
|
| 020 |
|
|
|a 9780309253161
|q (electronic bk.)
|
| 029 |
1 |
|
|a DEBBG
|b BV044109451
|
| 035 |
|
|
|a (OCoLC)902942425
|z (OCoLC)923289264
|
| 043 |
|
|
|a n-us---
|
| 050 |
|
4 |
|a R853.C55.E585 2012eb
|
| 082 |
0 |
4 |
|a 615.50724
|
| 049 |
|
|
|a UAMI
|
| 245 |
0 |
0 |
|a Envisioning a transformed clinical trials enterprise in the united states :
|b establishing ...
|
| 260 |
|
|
|a Washington :
|b National Academies Press,
|c 2012.
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 505 |
0 |
|
|a FrontMatter -- Reviewers -- Contents -- Tables, Figures, and Boxes -- Acronyms -- 1 Introduction -- 2 Integrating Community Practice and Clinical Trials -- 3 Improving Public Participation in Clinical Trials -- 4 Creating a New Business Model for Clinical Trials -- 5 Building an Infrastructure to Support Clinical Trials -- 6 Suggesting an Agenda for Transforming Elements of the Clinical Trials Enterprise -- References -- Appendix A: Workshop Agenda -- Appendix B: Participant Biographies -- Appendix C: Registered Workshop Attendees
|
| 505 |
8 |
|
|a Appendix D: Discussion Paper: The Clinical Trials Enterprise in the United States: A Call for Disruptive InnovationAppendix E: Discussion Paper: Developing a Robust Clinical Trials Workforce -- Appendix F: Discussion Paper: Transforming the Economics of Clinical Trials -- Appendix G: Discussion Paper: Developing a Clinical Trials Infrastructure -- Appendix H: Discussion Paper: Canadian Strategy on Patient-Oriented Research -- Appendix I: Discussion Paper: Health Research as a Public Good -- Appendix J: Discussion Paper: Novel Ways to Get Good Trial Data: The UK Experience
|
| 590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
| 650 |
|
0 |
|a Clinical trials
|z United States.
|
| 650 |
|
0 |
|a Clinical medicine
|x Research
|z United States.
|
| 650 |
|
6 |
|a Études cliniques
|z États-Unis.
|
| 650 |
|
6 |
|a Médecine clinique
|x Recherche
|z États-Unis.
|
| 650 |
|
7 |
|a Clinical medicine
|x Research
|2 fast
|
| 650 |
|
7 |
|a Clinical trials
|2 fast
|
| 651 |
|
7 |
|a United States
|2 fast
|1 https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq
|
| 776 |
0 |
8 |
|i Print version:
|a Weisfeld, Neil.
|t Envisioning a Transformed Clinical Trials Enterprise in the United States : Establishing an Agenda for 2020: Workshop Summary.
|d Washington : National Academies Press, ©1900
|z 9780309253154
|
| 856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=3379028
|z Texto completo
|
| 938 |
|
|
|a EBL - Ebook Library
|b EBLB
|n EBL3379028
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 9753180
|
| 994 |
|
|
|a 92
|b IZTAP
|
